Fifty shades of graft: How to improve the efficacy of faecal microbiota transplantation for decolonization of antibiotic-resistant bacteria.


Journal

International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860

Informations de publication

Date de publication:
May 2019
Historique:
received: 14 01 2019
revised: 04 03 2019
accepted: 09 03 2019
pubmed: 19 3 2019
medline: 9 8 2019
entrez: 19 3 2019
Statut: ppublish

Résumé

Spontaneous decolonization of antibiotic-resistant bacteria (ARB) takes time: approximately 25% after 30 days for carbapenem-producing Enterobacteriaceae or extended-spectrum beta-lactamase-producing Enterobacteriaceae. Faecal microbiota transplantation (FMT) has been proposed as a new strategy to promote decolonization in order to reduce the risk of superinfection due to these ARB. This paper discusses the literature on the use of FMT for this indication, and the improvement levers available to promote its efficacy. Literature available to date concerning the use of FMT to eradicate ARB was reviewed, and the different factors that may have influenced the efficacy of decolonization were evaluated. Four axes that could have played major roles in the efficacy of FMT were identified: bowel preparation before FMT; donor; dose; and thermal conditioning of faeces. The positive or negative impact of each on the outcome of FMT is discussed. Although FMT is very efficient for the eradication of Clostridium difficile, the same 'recipe' cannot be used for the eradication of ARB. Working together with expert centres may help to improve the efficacy of FMT for this indication, and enable the reduction of in-hospital isolation precautions.

Sections du résumé

BACKGROUND BACKGROUND
Spontaneous decolonization of antibiotic-resistant bacteria (ARB) takes time: approximately 25% after 30 days for carbapenem-producing Enterobacteriaceae or extended-spectrum beta-lactamase-producing Enterobacteriaceae. Faecal microbiota transplantation (FMT) has been proposed as a new strategy to promote decolonization in order to reduce the risk of superinfection due to these ARB. This paper discusses the literature on the use of FMT for this indication, and the improvement levers available to promote its efficacy.
METHODS METHODS
Literature available to date concerning the use of FMT to eradicate ARB was reviewed, and the different factors that may have influenced the efficacy of decolonization were evaluated.
RESULTS RESULTS
Four axes that could have played major roles in the efficacy of FMT were identified: bowel preparation before FMT; donor; dose; and thermal conditioning of faeces. The positive or negative impact of each on the outcome of FMT is discussed.
CONCLUSION CONCLUSIONS
Although FMT is very efficient for the eradication of Clostridium difficile, the same 'recipe' cannot be used for the eradication of ARB. Working together with expert centres may help to improve the efficacy of FMT for this indication, and enable the reduction of in-hospital isolation precautions.

Identifiants

pubmed: 30880228
pii: S0924-8579(19)30061-5
doi: 10.1016/j.ijantimicag.2019.03.008
pii:
doi:

Types de publication

Editorial Systematic Review

Langues

eng

Pagination

553-556

Informations de copyright

Copyright © 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.

Auteurs

Benjamin Davido (B)

Maladies Infectieuses, Hôpital Universitaire Raymond-Poincaré, Groupe Hospitalier Paris Ile de France Ouest, AP-HP, Garches, France. Electronic address: benjamin.davido@aphp.fr.

Rui Batista (R)

Pharmacie Hospitalière, Hôpital Universitaire Cochin, AP-HP, Paris, France.

Aurélien Dinh (A)

Maladies Infectieuses, Hôpital Universitaire Raymond-Poincaré, Groupe Hospitalier Paris Ile de France Ouest, AP-HP, Garches, France.

Pierre de Truchis (P)

Maladies Infectieuses, Hôpital Universitaire Raymond-Poincaré, Groupe Hospitalier Paris Ile de France Ouest, AP-HP, Garches, France.

E M Terveer (EM)

Department of Medical Microbiology, Leiden, The Netherlands; Netherlands Donor Faeces Bank at Leiden University Medical Centre, Leiden, The Netherlands.

Bruce Roberts (B)

Vedanta Biosciences Inc., Cambridge, MA, USA.

Ed J Kuijper (EJ)

Department of Medical Microbiology, Leiden, The Netherlands; Netherlands Donor Faeces Bank at Leiden University Medical Centre, Leiden, The Netherlands.

Silvia Caballero (S)

Vedanta Biosciences Inc., Cambridge, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH